Mumbai: Pinning all differences after the row over the coronavirus vaccine, the Serum Institute of India and Bharat Biotech issued a joint statement on Tuesday and said the two companies have promised to work jointly on the vaccine rollout project.
In a joint statement, the two companies stated that their joint intention is to develop, manufacture and supply Covid-19 vaccines for India and the world.
“We are fully aware of the importance of vaccines for people and countries alike, we hereby communicate our joint pledge to provide global access for our COVID-19 vaccines,” the Joint statement of Serum Institute of India and Bharat Biotech reads.
“The more important task in front of us is saving the lives and livelihoods of populations in India and the world. Vaccines are a global public health good and they have the power to save lives and accelerate the return to economic normalcy at the earliest,” the joint statement read.
In the statement, the two companies have also agreed that they are fully engaged in this activity and consider it their duty to the country and the world at large to ensure a smooth rollout of the vaccine.
“They (Adar Poonawala and Dr Krishna Ella] said, the more important task before they are saving the lives and livelihoods of the population in India and the world. Vaccines are a global public health good and they have the ability to save lives and as soon as possible The economic situation has the power to accelerate the return.
SII and Bharat Biotech stated that the focus is on manufacturing, supply and distribution, a population that needs to obtain high quality, safe and effective vaccines.
“Both our companies are fully engaged in this activity and consider it our duty to the country and the world at large to ensure a smooth rollout of the vaccine. Each of our companies has continued its Cmore critical work, saving lives and livelihood-19 vaccine development activities in a planned manner.”
The firms added, “We are fully aware of the importance of vaccines for people and countries alike, we hereby communicate our joint pledge to provide global access for our Covid-19 vaccines.”
Notably, vaccines developed by Serum Institute and Bharat Biotech have been approved by the regulatory authority for restricted emergency use. Bharat Biotech’s Covaxin was approved for emergency use by Drug Controller General of India on Sunday along with Oxford Covid-19 vaccine Covishield, manufactured by the Serum Institute.